Literature DB >> 34105510

Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study.

Laura Bojke1, Marta Soares1, Karl Claxton1, Abigail Colson2, Aimée Fox1, Christopher Jackson3, Dina Jankovic1, Alec Morton2, Linda Sharples4, Andrea Taylor5.   

Abstract

BACKGROUND: Many decisions in health care aim to maximise health, requiring judgements about interventions that may have higher health effects but potentially incur additional costs (cost-effectiveness framework). The evidence used to establish cost-effectiveness is typically uncertain and it is important that this uncertainty is characterised. In situations in which evidence is uncertain, the experience of experts is essential. The process by which the beliefs of experts can be formally collected in a quantitative manner is structured expert elicitation. There is heterogeneity in the existing methodology used in health-care decision-making. A number of guidelines are available for structured expert elicitation; however, it is not clear if any of these are appropriate for health-care decision-making.
OBJECTIVES: The overall aim was to establish a protocol for structured expert elicitation to inform health-care decision-making. The objectives are to (1) provide clarity on methods for collecting and using experts' judgements, (2) consider when alternative methodology may be required in particular contexts, (3) establish preferred approaches for elicitation on a range of parameters, (4) determine which elicitation methods allow experts to express uncertainty and (5) determine the usefulness of the reference protocol developed.
METHODS: A mixed-methods approach was used: systemic review, targeted searches, experimental work and narrative synthesis. A review of the existing guidelines for structured expert elicitation was conducted. This identified the approaches used in existing guidelines (the 'choices') and determined if dominant approaches exist. Targeted review searches were conducted for selection of experts, level of elicitation, fitting and aggregation, assessing accuracy of judgements and heuristics and biases. To sift through the available choices, a set of principles that underpin the use of structured expert elicitation in health-care decision-making was defined using evidence generated from the targeted searches, quantities to elicit experimental evidence and consideration of constraints in health-care decision-making. These principles, including fitness for purpose and reflecting individual expert uncertainty, were applied to the set of choices to establish a reference protocol. An applied evaluation of the developed reference protocol was also undertaken.
RESULTS: For many elements of structured expert elicitation, there was a lack of consistency across the existing guidelines. In almost all choices, there was a lack of empirical evidence supporting recommendations, and in some circumstances the principles are unable to provide sufficient justification for discounting particular choices. It is possible to define reference methods for health technology assessment. These include a focus on gathering experts with substantive skills, eliciting observable quantities and individual elicitation of beliefs. Additional considerations are required for decision-makers outside health technology assessment, for example at a local level, or for early technologies. Access to experts may be limited and in some circumstances group discussion may be needed to generate a distribution. LIMITATIONS: The major limitation of the work conducted here lies not in the methods employed in the current work but in the evidence available from the wider literature relating to how appropriate particular methodological choices are.
CONCLUSIONS: The reference protocol is flexible in many choices. This may be a useful characteristic, as it is possible to apply this reference protocol across different settings. Further applied studies, which use the choices specified in this reference protocol, are required. FUNDING: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 25, No. 37. See the NIHR Journals Library website for further project information. This work was also funded by the Medical Research Council (reference MR/N028511/1).

Entities:  

Keywords:  DECISION-MAKING; EXPERT ELICITATION; HEALTH; TRANSPARENCY; UNCERTAINTY

Mesh:

Year:  2021        PMID: 34105510      PMCID: PMC8215568          DOI: 10.3310/hta25370

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


  83 in total

1.  A piecewise-homogeneous Markov chain process of lung transplantation.

Authors:  L D Sharples; G I Taylor; M Faddy
Journal:  J Epidemiol Biostat       Date:  2001

2.  Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model Uncertainties.

Authors:  Laura Bojke; Bogdan Grigore; Dina Jankovic; Jaime Peters; Marta Soares; Ken Stein
Journal:  Pharmacoeconomics       Date:  2017-09       Impact factor: 4.981

3.  Use (and abuse) of expert elicitation in support of decision making for public policy.

Authors:  M Granger Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

Review 4.  Enhanced external counterpulsation for the treatment of stable angina and heart failure: a systematic review and economic analysis.

Authors:  C McKenna; C McDaid; S Suekarran; N Hawkins; K Claxton; K Light; M Chester; J Cleland; N Woolacott; M Sculpher
Journal:  Health Technol Assess       Date:  2009-04       Impact factor: 4.014

5.  The cost-effectiveness of an RCT to establish whether 5 or 10 years of bisphosphonate treatment is the better duration for women with a prior fracture.

Authors:  Matt D Stevenson; Jeremy E Oakley; Myfawny Lloyd Jones; Alan Brennan; Juliet E Compston; Eugene V McCloskey; Peter L Selby
Journal:  Med Decis Making       Date:  2009-06-09       Impact factor: 2.583

Review 6.  Using value of information analysis to prioritise health research: some lessons from recent UK experience.

Authors:  Karl P Claxton; Mark J Sculpher
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

7.  The Long-Term Cost to the UK NHS and Social Services of Different Durations of IV Thiamine (Vitamin B1) for Chronic Alcohol Misusers with Symptoms of Wernicke's Encephalopathy Presenting at the Emergency Department.

Authors:  Edward C F Wilson; George Stanley; Zulfiquar Mirza
Journal:  Appl Health Econ Health Policy       Date:  2016-04       Impact factor: 2.561

8.  Bayesian treatment comparison using parametric mixture priors computed from elicited histograms.

Authors:  Peter F Thall; Moreno Ursino; Véronique Baudouin; Corinne Alberti; Sarah Zohar
Journal:  Stat Methods Med Res       Date:  2017-09-05       Impact factor: 3.021

9.  Quantifying uncertainty about future antimicrobial resistance: Comparing structured expert judgment and statistical forecasting methods.

Authors:  Abigail R Colson; Itamar Megiddo; Gerardo Alvarez-Uria; Sumanth Gandra; Tim Bedford; Alec Morton; Roger M Cooke; Ramanan Laxminarayan
Journal:  PLoS One       Date:  2019-07-05       Impact factor: 3.240

10.  Health Opportunity Costs: Assessing the Implications of Uncertainty Using Elicitation Methods with Experts.

Authors:  Marta O Soares; Mark J Sculpher; Karl Claxton
Journal:  Med Decis Making       Date:  2020-05-22       Impact factor: 2.583

View more
  5 in total

1.  Family Spillover Effects: Are Economic Evaluations Misrepresenting the Value of Healthcare Interventions to Society?

Authors:  Ashley A Leech; Pei-Jung Lin; Brittany D'Cruz; Susan K Parsons; Tara A Lavelle
Journal:  Appl Health Econ Health Policy       Date:  2022-08-23       Impact factor: 3.686

Review 2.  A checklist for assessing the methodological quality of concurrent tES-fMRI studies (ContES checklist): a consensus study and statement.

Authors:  Hamed Ekhtiari; Peyman Ghobadi-Azbari; Axel Thielscher; Andrea Antal; Lucia M Li; A Duke Shereen; Yuranny Cabral-Calderin; Daniel Keeser; Til Ole Bergmann; Asif Jamil; Ines R Violante; Jorge Almeida; Marcus Meinzer; Hartwig R Siebner; Adam J Woods; Charlotte J Stagg; Rany Abend; Daria Antonenko; Tibor Auer; Marc Bächinger; Chris Baeken; Helen C Barron; Henry W Chase; Jenny Crinion; Abhishek Datta; Matthew H Davis; Mohsen Ebrahimi; Zeinab Esmaeilpour; Brian Falcone; Valentina Fiori; Iman Ghodratitoostani; Gadi Gilam; Roland H Grabner; Joel D Greenspan; Georg Groen; Gesa Hartwigsen; Tobias U Hauser; Christoph S Herrmann; Chi-Hung Juan; Bart Krekelberg; Stephanie Lefebvre; Sook-Lei Liew; Kristoffer H Madsen; Rasoul Mahdavifar-Khayati; Nastaran Malmir; Paola Marangolo; Andrew K Martin; Timothy J Meeker; Hossein Mohaddes Ardabili; Marius Moisa; Davide Momi; Beni Mulyana; Alexander Opitz; Natasza Orlov; Patrick Ragert; Christian C Ruff; Giulio Ruffini; Michaela Ruttorf; Arshiya Sangchooli; Klaus Schellhorn; Gottfried Schlaug; Bernhard Sehm; Ghazaleh Soleimani; Hosna Tavakoli; Benjamin Thompson; Dagmar Timmann; Aki Tsuchiyagaito; Martin Ulrich; Johannes Vosskuhl; Christiane A Weinrich; Mehran Zare-Bidoky; Xiaochu Zhang; Benedikt Zoefel; Michael A Nitsche; Marom Bikson
Journal:  Nat Protoc       Date:  2022-02-04       Impact factor: 17.021

3.  Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced Melanoma.

Authors:  Victoria Federico Paly; Murat Kurt; Lirong Zhang; Marcus O Butler; Olivier Michielin; Adenike Amadi; Emma Hernlund; Helen M Johnson; Srividya Kotapati; Andriy Moshyk; John Borrill
Journal:  MDM Policy Pract       Date:  2022-03-26

4.  Engage, understand, listen and act: evaluation of Community Panels to privilege First Nations voices in pandemic planning and response in Australia.

Authors:  Kristy Crooks; Kylie Taylor; Charlee Law; Sandra Campbell; Adrian Miller
Journal:  BMJ Glob Health       Date:  2022-08

5.  Structured expert elicitation to inform long-term survival extrapolations using alternative parametric distributions: a case study of CAR T therapy for relapsed/ refractory multiple myeloma.

Authors:  Dieter Ayers; Shannon Cope; Kevin Towle; Ali Mojebi; Thomas Marshall; Devender Dhanda
Journal:  BMC Med Res Methodol       Date:  2022-10-15       Impact factor: 4.612

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.